Oral monthly ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study (MOPS)

Jean-Yves Reginster; E. Dumont; C. Wiese; K. Wilson; R. C. Schimmer

Back

Oral monthly ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study (MOPS)

Conference proceeding

Peer reviewed

Oral monthly ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study (MOPS)

Jean-Yves Reginster, E. Dumont, C. Wiese, K. Wilson and R. C. Schimmer

Osteoporosis International, 15 (Suppl.1), S105-106 (2004-05); IOF World Congress on Osteoporosis, Rio de Janeiro, Brazil [BR], du 14 mai 2004 au 18 mai 2004

05/2004

Abstract

Endocrinologie, métabolisme & nutrition

Endocrinology, metabolism & nutrition

General & internal medicine

Human health sciences

Médecine générale & interne

Public health, health care sciences & services

Santé publique, services médicaux & soins de santé

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: Oral monthly ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study (MOPS)
Creators - without role: Jean-Yves Reginster
E. Dumont
C. Wiese
K. Wilson
R. C. Schimmer
Conference: Osteoporosis International, 15 (Suppl.1), S105-106 (2004-05); IOF World Congress on Osteoporosis, Rio de Janeiro, Brazil [BR], du 14 mai 2004 au 18 mai 2004
Publisher: Springer Science & Business Media B.V
Identifiers: 9952583608331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding